These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 30928250)
1. Prognostic significance of sarcopenia and skeletal muscle mass change during preoperative chemoradiotherapy in locally advanced rectal cancer. Chung E; Lee HS; Cho ES; Park EJ; Baik SH; Lee KY; Kang J Clin Nutr; 2020 Mar; 39(3):820-828. PubMed ID: 30928250 [TBL] [Abstract][Full Text] [Related]
2. Preoperative sarcopenia is a poor prognostic factor in lower rectal cancer patients undergoing neoadjuvant chemoradiotherapy: a retrospective study. Abe S; Kawai K; Nozawa H; Sasaki K; Murono K; Emoto S; Kishikawa J; Ishii H; Yokoyama Y; Nagai Y; Anzai H; Sonoda H; Oba K; Ishihara S Int J Clin Oncol; 2022 Jan; 27(1):141-153. PubMed ID: 34741193 [TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of persistent lower neutrophil-to-lymphocyte ratio during preoperative chemoradiotherapy in locally advanced rectal cancer patients: A propensity score matching analysis. Cha YJ; Park EJ; Baik SH; Lee KY; Kang J PLoS One; 2019; 14(3):e0214415. PubMed ID: 30901357 [TBL] [Abstract][Full Text] [Related]
4. Skeletal muscle loss is an independent negative prognostic factor in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy. Takeda Y; Akiyoshi T; Matsueda K; Fukuoka H; Ogura A; Miki H; Hiyoshi Y; Nagasaki T; Konishi T; Fujimoto Y; Fukunaga Y; Ueno M PLoS One; 2018; 13(4):e0195406. PubMed ID: 29630652 [TBL] [Abstract][Full Text] [Related]
5. Muscle wasting and survival following pre-operative chemoradiotherapy for locally advanced rectal carcinoma. Levolger S; van Vledder MG; Alberda WJ; Verhoef C; de Bruin RWF; IJzermans JNM; Burger JW Clin Nutr; 2018 Oct; 37(5):1728-1735. PubMed ID: 28756039 [TBL] [Abstract][Full Text] [Related]
6. Poor nutrition and sarcopenia are related to systemic inflammatory response in patients with rectal cancer undergoing preoperative chemoradiotherapy. Abe S; Nozawa H; Kawai K; Sasaki K; Murono K; Emoto S; Kishikawa J; Ozawa T; Yokoyama Y; Nagai Y; Anzai H; Sonoda H; Ishihara S Int J Colorectal Dis; 2022 Jan; 37(1):189-200. PubMed ID: 34633498 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer. Cheong C; Shin JS; Suh KW World J Gastroenterol; 2020 Nov; 26(44):7022-7035. PubMed ID: 33311947 [TBL] [Abstract][Full Text] [Related]
8. Sarcopenia is poor prognostic factor in older patients with locally advanced rectal cancer who received preoperative or postoperative chemoradiotherapy. Park SE; Hwang IG; Choi CH; Kang H; Kim BG; Park BK; Cha SJ; Jang JS; Choi JH Medicine (Baltimore); 2018 Nov; 97(48):e13363. PubMed ID: 30508928 [TBL] [Abstract][Full Text] [Related]
9. Endoscopic assessment of tumor regression after preoperative chemoradiotherapy as a prognostic marker in locally advanced rectal cancer. Sohn DK; Han KS; Kim BC; Hong CW; Chang HJ; Baek JY; Kim MJ; Park SC; Oh JH; Kim DY Surg Oncol; 2017 Dec; 26(4):453-459. PubMed ID: 29113665 [TBL] [Abstract][Full Text] [Related]
10. Systemic Inflammatory Response After Preoperative Chemoradiotherapy Can Affect Oncologic Outcomes in Locally Advanced Rectal Cancer. Lee IH; Hwang S; Lee SJ; Kang BW; Baek D; Kim HJ; Park SY; Park JS; Choi GS; Kim JC; Cho SH; Kim JG Anticancer Res; 2017 Mar; 37(3):1459-1465. PubMed ID: 28314318 [TBL] [Abstract][Full Text] [Related]
11. Skeletal Muscle Loss Is an Imaging Biomarker of Outcome after Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer. Lee J; Chang CL; Lin JB; Wu MH; Sun FJ; Jan YT; Hsu SM; Chen YJ Clin Cancer Res; 2018 Oct; 24(20):5028-5036. PubMed ID: 29959140 [No Abstract] [Full Text] [Related]
12. Prognosis of locally advanced rectal cancer can be predicted more accurately using pre- and post-chemoradiotherapy neutrophil-lymphocyte ratios in patients who received preoperative chemoradiotherapy. Sung S; Son SH; Park EY; Kay CS PLoS One; 2017; 12(3):e0173955. PubMed ID: 28291841 [TBL] [Abstract][Full Text] [Related]
13. Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer. Lin J; Peng J; Qdaisat A; Li L; Chen G; Lu Z; Wu X; Gao Y; Zeng Z; Ding P; Pan Z J Cancer Res Clin Oncol; 2016 Dec; 142(12):2551-2560. PubMed ID: 27613188 [TBL] [Abstract][Full Text] [Related]
14. Sarcopenia: An important prognostic factor for males treated for a locally advanced esophageal carcinoma. Benadon B; Servagi-Vernat S; Quero L; Cattan P; Guillerm S; Hennequin V; Aparicio T; Lourenço N; Bouché O; Hennequin C Dig Liver Dis; 2020 Sep; 52(9):1047-1052. PubMed ID: 32493629 [TBL] [Abstract][Full Text] [Related]
15. Severe muscle loss during radical chemoradiotherapy for non-metastatic nasopharyngeal carcinoma predicts poor survival. Huang X; Ma J; Li L; Zhu XD Cancer Med; 2019 Nov; 8(15):6604-6613. PubMed ID: 31517443 [TBL] [Abstract][Full Text] [Related]
16. Feasibility of Assessing Prognostic Nutrition Index in Patients With Rectal Cancer Who Receive Preoperative Chemoradiotherapy. Okugawa Y; Toiyama Y; Oki S; Ide S; Yamamoto A; Ichikawa T; Kitajima T; Fujikawa H; Yasuda H; Saigusa S; Hiro J; Yoshiyama S; Kobayashi M; Araki T; Kusunoki M JPEN J Parenter Enteral Nutr; 2018 Aug; 42(6):998-1007. PubMed ID: 29786882 [TBL] [Abstract][Full Text] [Related]
17. Tumor volume reduction rate after preoperative chemoradiotherapy as a prognostic factor in locally advanced rectal cancer. Yeo SG; Kim DY; Park JW; Oh JH; Kim SY; Chang HJ; Kim TH; Kim BC; Sohn DK; Kim MJ Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e193-9. PubMed ID: 21605941 [TBL] [Abstract][Full Text] [Related]
18. Early Skeletal Muscle Loss in Non-Small Cell Lung Cancer Patients Receiving Chemoradiation and Relationship to Survival. Kiss N; Beraldo J; Everitt S Support Care Cancer; 2019 Jul; 27(7):2657-2664. PubMed ID: 30478673 [TBL] [Abstract][Full Text] [Related]
19. Stage-to-stage comparison of preoperative and postoperative chemoradiotherapy for T3 mid or distal rectal cancer. Yeo SG; Kim DY; Park JW; Choi HS; Oh JH; Kim SY; Chang HJ; Kim TH; Sohn DK Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):856-62. PubMed ID: 21300482 [TBL] [Abstract][Full Text] [Related]